Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report)'s share price reached a new 52-week low on Thursday . The company traded as low as $12.87 and last traded at $13.09, with a volume of 368636 shares. The stock had previously closed at $13.11.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on ARDT. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Royal Bank of Canada cut their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Tuesday, March 4th. Truist Financial lowered their target price on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Morgan Stanley dropped their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Finally, Stephens restated an "overweight" rating and set a $22.00 target price on shares of Ardent Health Partners in a research note on Wednesday, March 26th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Ardent Health Partners presently has an average rating of "Buy" and an average price target of $21.18.
View Our Latest Analysis on Ardent Health Partners
Ardent Health Partners Stock Up 4.4 %
The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The firm has a 50-day simple moving average of $14.40 and a two-hundred day simple moving average of $16.19.
Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion during the quarter, compared to analysts' expectations of $1.48 billion. On average, research analysts anticipate that Ardent Health Partners, LLC will post 1.23 EPS for the current year.
Hedge Funds Weigh In On Ardent Health Partners
Several institutional investors and hedge funds have recently bought and sold shares of ARDT. State Street Corp purchased a new stake in shares of Ardent Health Partners during the 3rd quarter valued at $1,977,000. Jane Street Group LLC purchased a new stake in Ardent Health Partners during the third quarter valued at about $567,000. Barclays PLC acquired a new stake in Ardent Health Partners during the third quarter worth about $385,000. Geode Capital Management LLC purchased a new position in shares of Ardent Health Partners in the 3rd quarter worth about $2,581,000. Finally, JPMorgan Chase & Co. acquired a new position in shares of Ardent Health Partners in the 3rd quarter valued at about $154,000.
About Ardent Health Partners
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Read More
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
